These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 11564577)
1. Amplification and protein expression of chromosome 12q13-15 genes in osteosarcomas of the jaws. Lopes MA; Nikitakis NG; Ord RA; Sauk J Oral Oncol; 2001 Oct; 37(7):566-71. PubMed ID: 11564577 [TBL] [Abstract][Full Text] [Related]
2. Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma. Ragazzini P; Gamberi G; Benassi MS; Orlando C; Sestini R; Ferrari C; Molendini L; Sollazzo MR; Merli M; Magagnoli G; Bertoni F; Bohling T; Pazzagli M; Picci P Cancer Detect Prev; 1999; 23(2):129-36. PubMed ID: 10101594 [TBL] [Abstract][Full Text] [Related]
3. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation. Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873 [TBL] [Abstract][Full Text] [Related]
4. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. Reifenberger G; Ichimura K; Reifenberger J; Elkahloun AG; Meltzer PS; Collins VP Cancer Res; 1996 Nov; 56(22):5141-5. PubMed ID: 8912848 [TBL] [Abstract][Full Text] [Related]
5. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours. Dei Tos AP; Doglioni C; Piccinin S; Sciot R; Furlanetto A; Boiocchi M; Dal Cin P; Maestro R; Fletcher CD; Tallini G J Pathol; 2000 Apr; 190(5):531-6. PubMed ID: 10727978 [TBL] [Abstract][Full Text] [Related]
6. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone. Dujardin F; Binh MB; Bouvier C; Gomez-Brouchet A; Larousserie F; Muret Ad; Louis-Brennetot C; Aurias A; Coindre JM; Guillou L; Pedeutour F; Duval H; Collin C; de Pinieux G Mod Pathol; 2011 May; 24(5):624-37. PubMed ID: 21336260 [TBL] [Abstract][Full Text] [Related]
7. Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas. Wunder JS; Eppert K; Burrow SR; Gokgoz N; Bell RS; Andrulis IL Oncogene; 1999 Jan; 18(3):783-8. PubMed ID: 9989829 [TBL] [Abstract][Full Text] [Related]
8. Analysis of 12q13-15 genes in parosteal osteosarcoma. Gamberi G; Ragazzini P; Benassi MS; Ferrari C; Sollazzo MR; Molendini L; Merli M; Magagnoli G; Ruggieri P; Balladelli A; Orlando C; Bacchini P; Pazzagli M; Picci P Clin Orthop Relat Res; 2000 Aug; (377):195-204. PubMed ID: 10943202 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma. Mejia-Guerrero S; Quejada M; Gokgoz N; Gill M; Parkes RK; Wunder JS; Andrulis IL Genes Chromosomes Cancer; 2010 Jun; 49(6):518-25. PubMed ID: 20196171 [TBL] [Abstract][Full Text] [Related]
11. Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas. Berner JM; Forus A; Elkahloun A; Meltzer PS; Fodstad O; Myklebost O Genes Chromosomes Cancer; 1996 Dec; 17(4):254-9. PubMed ID: 8946207 [TBL] [Abstract][Full Text] [Related]
12. MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype. Yoshida A; Ushiku T; Motoi T; Beppu Y; Fukayama M; Tsuda H; Shibata T Am J Surg Pathol; 2012 Mar; 36(3):423-31. PubMed ID: 22301501 [TBL] [Abstract][Full Text] [Related]
13. CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons. Wei G; Lonardo F; Ueda T; Kim T; Huvos AG; Healey JH; Ladanyi M Int J Cancer; 1999 Jan; 80(2):199-204. PubMed ID: 9935200 [TBL] [Abstract][Full Text] [Related]
14. CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus. Hernández L; Beà S; Pinyol M; Ott G; Katzenberger T; Rosenwald A; Bosch F; López-Guillermo A; Delabie J; Colomer D; Montserrat E; Campo E Cancer Res; 2005 Mar; 65(6):2199-206. PubMed ID: 15781632 [TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of p53, MDM2 and H-ras genes in low-grade central osteosarcoma. Park HR; Jung WW; Bertoni F; Bacchini P; Park JH; Kim YW; Park YK Pathol Res Pract; 2004; 200(6):439-45. PubMed ID: 15310147 [TBL] [Abstract][Full Text] [Related]
16. Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22. Pilotti S; Della Torre G; Lavarino C; Sozzi G; Minoletti F; Vergani B; Azzarelli A; Rilke F; Pierotti MA J Pathol; 1998 Jun; 185(2):188-90. PubMed ID: 9713346 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material: a potential tool for the diagnosis of atypical lipomatous tumours/well-differentiated liposarcomas. Hostein I; Pelmus M; Aurias A; Pedeutour F; Mathoulin-Pélissier S; Coindre JM J Pathol; 2004 Jan; 202(1):95-102. PubMed ID: 14694526 [TBL] [Abstract][Full Text] [Related]
18. MDM2 and CDK4 expression in periosteal osteosarcoma. Righi A; Gambarotti M; Benini S; Gamberi G; Cocchi S; Picci P; Bertoni F Hum Pathol; 2015 Apr; 46(4):549-53. PubMed ID: 25680902 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and immunohistochemical analysis of twenty-five head and neck osteosarcomas. Junior AT; de Abreu Alves F; Pinto CA; Carvalho AL; Kowalski LP; Lopes MA Oral Oncol; 2003 Jul; 39(5):521-30. PubMed ID: 12747978 [TBL] [Abstract][Full Text] [Related]
20. Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity. Coindre JM; Hostein I; Maire G; Derré J; Guillou L; Leroux A; Ghnassia JP; Collin F; Pedeutour F; Aurias A J Pathol; 2004 Jul; 203(3):822-30. PubMed ID: 15221942 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]